Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Accuracy of MRI, Diffusion-weighted MRI, FDG-PET/CT and Fluoro-ethyl-choline PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

NCT01836484 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT01836484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01836484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Accuracy of MRI, Diffusion-weighted MRI, FDG-PET/CT and Fluoro-ethyl-choline PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
Lead sponsor
Barts & The London NHS Trust
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
December 31, 2018
Enrollment
162 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer: invasive disease, figo stage 1b1 or higher, endometrial cancer, stage 1a with myometrial invasion or any higher stage and grade 3, stage 1a with myometrial invasion or any other higher stage and serous papillary or clear cell sub-types, stage ii disease or above and any histology grade, surgically staged endometrial and cervical carcinoma